Literature DB >> 8170151

Bufo alvarius: a potent hallucinogen of animal origin.

A T Weil1, W Davis.   

Abstract

Anthropologists have long speculated that ancient peoples of Mesoameria used a toad, Bufo marinus, as a ritual intoxicant. This hypothesis rests on many iconographic and mythological representations of toads and on a number of speculative ethnographic reports. The authors reject B. marinus as a candidate for such use because of the toxicity of its venom. A more likely candidate is the Sonoran desert toad, Bufo alvarius, which secretes large amounts of the potent known hallucinogen, 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT). The authors demonstrate that the venom of B. alvarius, although known to be toxic when consumed orally, may be safely smoked and is powerfully psychoactive by that route of administration. These experiments are the first documentation of an hallucinogenic agent from the animal kingdom, and they provide clear evidence of a psychoactive toad that could have been employed by Precolumbian peoples of the New World.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8170151     DOI: 10.1016/0378-8741(94)90051-5

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  23 in total

Review 1.  [Party and designer drugs : From ecstasy and crystal meth to angel's trumpet].

Authors:  F Erbguth
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-10-19       Impact factor: 0.840

2.  The epidemiology of 5-methoxy- N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption.

Authors:  Alan K Davis; Joseph P Barsuglia; Rafael Lancelotta; Robert M Grant; Elise Renn
Journal:  J Psychopharmacol       Date:  2018-04-30       Impact factor: 4.153

3.  'Foxtrot' fumarate: a water-soluble salt of N,N-di-allyl-5-methoxytryptamine (5-MeO-DALT).

Authors:  Duyen N K Pham; Vamshikrishna Reddy Sammeta; Andrew R Chadeayne; James A Golen; David R Manke
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2021-03-19

4.  Biochemical Analyses of Proteins from Duttaphrynus melanostictus (Bufo melanostictus) Skin Secretion: Soluble Protein Retrieval from a Viscous Matrix by Ion-Exchange Batch Sample Preparation.

Authors:  Douglas O C Mariano; Marcela Di Giacomo Messias; José Pedro Prezotto-Neto; Patrick J Spencer; Daniel C Pimenta
Journal:  Protein J       Date:  2018-08       Impact factor: 2.371

Review 5.  Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions.

Authors:  Hong-Wu Shen; Xi-Ling Jiang; Jerrold C Winter; Ai-Ming Yu
Journal:  Curr Drug Metab       Date:  2010-10       Impact factor: 3.731

6.  Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects.

Authors:  Rafael L Lancelotta; Alan K Davis
Journal:  J Psychoactive Drugs       Date:  2020-03-09

Review 7.  Biosynthesis and synthetic biology of psychoactive natural products.

Authors:  Cooper S Jamieson; Joshua Misa; Yi Tang; John M Billingsley
Journal:  Chem Soc Rev       Date:  2021-06-21       Impact factor: 60.615

8.  The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides.

Authors:  P Mallaroni; N L Mason; F R J Vinckenbosch; J G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2022-04-30       Impact factor: 4.415

9.  Detection of antidiabetic activity by crude paratoid gland secretions from common Indian toad (bufomelano stictus).

Authors:  Prasad Neerati
Journal:  J Nat Sci Biol Med       Date:  2015 Jul-Dec

10.  Miniaturized bioaffinity assessment coupled to mass spectrometry for guided purification of bioactives from toad and cone snail.

Authors:  Ferry Heus; Reka A Otvos; Ruud L E G Aspers; Rene van Elk; Jenny I Halff; Andreas W Ehlers; Sébastien Dutertre; Richard J Lewis; Sybren Wijmenga; August B Smit; Wilfried M A Niessen; Jeroen Kool
Journal:  Biology (Basel)       Date:  2014-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.